Alphagan p and Soma drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan p (brimonidine tartrate) and Soma (carisoprodol). Common drug interactions include activities of daily living impaired among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan p and Soma. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan p?

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 6,579 Alphagan p users. Check the latest studies of Alphagan p.

What is Soma?

Soma has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 17,137 Soma users. Check the latest studies of Soma.



On Jul, 29, 2026

19 people who take Alphagan p and Soma together, and have interactions are studied.

Alphagan p and Soma drug interactions.

What are the common drug interactions of Alphagan P and Soma, by gender? *:

female:

  1. Activities of daily living impaired
  2. Agitation (state of anxiety or nervous excitement)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Arrhythmia (irregular heartbeat)
  6. Arteriosclerosis (thickening and hardening of arteries)
  7. Arthralgia (joint pain)
  8. Arthropathy
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  10. Balance disorder

male:

  1. Abscess (pus)
  2. Activities of daily living impaired
  3. Bone disorder
  4. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Calculus urinary (stone in urinary system)
  7. Cardiac failure congestive
  8. Cardiomegaly (increased size of heart than normal)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Alphagan P and Soma, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  2. Balance disorder
  3. Blood glucose increased
  4. Bone cyst
  5. Bone disorder
  6. Bone swelling
  7. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Calculus urinary (stone in urinary system)
  10. Cardiac failure congestive

40-49:

n/a

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abscess (pus)
  3. Bone cyst
  4. Bone disorder
  5. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  6. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  7. Calculus urinary (stone in urinary system)
  8. Cardiac failure congestive
  9. Cardiomegaly (increased size of heart than normal)
  10. Cardiomyopathy (weakening of the heart muscle)

What are the existing conditions these people have? *

  1. Toothaches (tooth pain): 11 people, 57.89%
  2. Depression: 4 people, 21.05%
  3. Bone Neoplasm Malignant (cancer of bone): 3 people, 15.79%
  4. Sleep Disorder: 2 people, 10.53%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 10.53%
  6. Nausea (feeling of having an urge to vomit): 2 people, 10.53%
  7. Stress And Anxiety: 1 person, 5.26%
  8. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.26%
  9. Parkinson's Disease: 1 person, 5.26%
  10. Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan p and Soma?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alphagan p and Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alphagan p:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alphagan p and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soma and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate and carisoprodol (the active ingredients of Alphagan p and Soma, respectively), and Alphagan p and Soma (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: